Cargando…

Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection

In fecal microbiota transplantation (FMT) against recurrent Clostridioides difficile infection (CDI), clinical outcomes are usually determined after 8 weeks. We hypothesized that the intestinal microbiota changes earlier than this timepoint, and analyzed fecal samples obtained 1 week after treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Shaodong, Bahl, Martin Iain, Baunwall, Simon Mark Dahl, Dahlerup, Jens Frederik, Hvas, Christian Lodberg, Licht, Tine Rask
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176232/ https://www.ncbi.nlm.nih.gov/pubmed/36519447 http://dx.doi.org/10.1080/19490976.2022.2084306

Ejemplares similares

Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances
por: Wei, Shaodong, et al.
Publicado: (2021)

Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis
por: Baunwall, Simon Mark Dahl, et al.
Publicado: (2020)

Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection
por: Eriksen, Lotte Lindgreen, et al.
Publicado: (2021)

Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report
por: Wei, Shaodong, et al.
Publicado: (2022)

Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review
por: Hammeken, Lianna Hede, et al.
Publicado: (2021)

Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy
por: Cold, Frederik, et al.
Publicado: (2021)

Health-related quality of life in patients with recurrent Clostridioides difficile infections
por: Hammeken, Lianna H., et al.
Publicado: (2022)

Settlers of our inner surface – factors shaping the gut microbiota from birth to toddlerhood
por: Laursen, Martin Frederik, et al.
Publicado: (2021)

Banking feces: a new frontier for public blood banks?
por: Jørgensen, Simon Mark Dahl, et al.
Publicado: (2019)

Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)

Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity
por: Hvas, Christian Lodberg, et al.
Publicado: (2020)

Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Soveral, Lucas F, et al.
Publicado: (2022)

Hypophosphatemia in a Specialized Intestinal Failure Unit: An Observational Cohort Study
por: Eriksen, Marcel Kjærsgaard, et al.
Publicado: (2020)

Faecal microbiota transplantation as a home therapy to frail older people
por: Jørgensen, Simon Mark Dahl, et al.
Publicado: (2020)

Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
por: Hernández, Marta, et al.
Publicado: (2019)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
por: Moon, Chang Mo, et al.
Publicado: (2021)

Having older siblings is associated with gut microbiota development during early childhood
por: Laursen, Martin Frederik, et al.
Publicado: (2015)

Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections
por: Grosen, Anne Karmisholt, et al.
Publicado: (2019)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023)

Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
por: van Lingen, Emilie (E.), et al.
Publicado: (2023)

Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Björkqvist, Olle, et al.
Publicado: (2021)

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2021)

Frailty level at discharge predicts mortality in older patients with Clostridioides difficile more accurately than age or disease severity
por: Rubak, Tone, et al.
Publicado: (2023)

Infant Gut Microbiota Development Is Driven by Transition to Family Foods Independent of Maternal Obesity
por: Laursen, Martin Frederik, et al.
Publicado: (2016)

Maternal milk microbiota and oligosaccharides contribute to the infant gut microbiota assembly
por: Laursen, Martin Frederik, et al.
Publicado: (2021)

Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation
por: Laursen, Martin Frederik, et al.
Publicado: (2017)

792. Evaluation of Persistent Diarrhea and Recurrence Following Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
por: Boton, Noah, et al.
Publicado: (2020)

Changes in IgA-targeted microbiota following fecal transplantation for recurrent Clostridioides difficile infection
por: Huus, Kelsey E, et al.
Publicado: (2020)

Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients
por: Ali, Hiba, et al.
Publicado: (2021)

Microbial ecology between Clostridioides difficile and gut microbiota
por: KAMIYA, Shigeru
Publicado: (2023)

Human milk oligosaccharides induce acute yet reversible compositional changes in the gut microbiota of conventional mice linked to a reduction of butyrate levels
por: Holst, Andrea Qvortrup, et al.
Publicado: (2022)

Clinical response and changes in the fecal microbiota and metabolite levels after fecal microbiota transplantation in patients with inflammatory bowel disease and recurrent Clostridioides difficile infection
por: Osaki, Hayato, et al.
Publicado: (2021)

Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
por: Steed, Danielle Barrios, et al.
Publicado: (2020)

2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Saha, Srishti, et al.
Publicado: (2019)

Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease
por: Meighani, Alireza, et al.
Publicado: (2020)

Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Clostridioides difficile Infection
por: Cho, Young-Seok
Publicado: (2021)

Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection
por: Yoon, Hyuk, et al.
Publicado: (2021)

Ischemic colitis complicated by Clostridioides difficile infection treated with fecal microbiota transplantation
por: Kang, Seok Hyung, et al.
Publicado: (2023)

Interactions Between Clostridioides difficile and Fecal Microbiota in in Vitro Batch Model: Growth, Sporulation, and Microbiota Changes
por: Horvat, Sabina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lhhu0ipnbuk2f4rudvhse1hf8s